Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression-Reference-Cited by-同舟云学术

Efficacy and safety of telaprevir with natural human interferon-β and ribavirin in Japanese chronic hepatitis C patients with depression

Published:2017-07-19 Issue:2 Volume:48 Page:184-192
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Kumada Hiromitsu¹,Mochida Satoshi²,Nakamuta Makoto³,Suzuki Fumitaka¹,Yagi Takashi⁴,Takasaki Ryuji⁴,Okai Masao⁴,Kamiya Naohiro⁵,Okada Yasushi⁶,Hirota Saya⁵,Orihashi Madori⁵,Ochi Miyoko⁵,Chayama Kazuaki⁷

Affiliation:

1. Department of Hepatology; Toranomon Hospital; Tokyo Japan

2. Department of Gastroenterology and Hepatology, Faculty of Medicine; Saitama Medical University; Saitama Japan

3. Department of Gastroenterology, Kyushu Medical Center, Clinical Research Center; National Hospital Organization; Fukuoka Japan

4. Pharmaceutical Clinical Research Department; Toray Industries, Inc.; Tokyo Japan

5. SOHYAKU. Innovative Research Division; Mitsubishi Tanabe Pharma Corporation; Tokyo Japan

6. IKUYAKU. Integrated Value Development Division; Mitsubishi Tanabe Pharma Corporation; Tokyo Japan

7. Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science; Hiroshima University; Hiroshima Japan

Funder

Mitsubishi Tanabe Pharma Corporation and Toray Industries, Inc

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12914/fullpdf

Reference28 articles.

1. World Health Organization 2016 http://www.who.int/mediacentre/factsheets/fs164/en/

2. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010

3. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan;Kumada;J Hepatol,2012

4. Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C;Hayashi;J Viral Hepat,2012

5. Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan;Kumada;Hepatology Res,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect;American Journal of Health-System Pharmacy;2021-02-22